Fishawack continues to build best-in-class service offering with Dudnyk acquisition
Fishawack, a leading independent healthcare communications specialist, is excited to announce its acquisition of Dudnyk, the Philadelphia-based healthcare communications agency. Dudnyk is an award-winning, full-service agency that specializes in creating insight-driven, authentic brand experiences that unite specialty physicians and their patients. They leverage strategic, scientific, and creative capabilities to serve clients in the biotech, pharmaceutical, and medical device industries.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190320005204/en/
Dudnyk leadership team includes Christopher Tobias, PhD, President; Laurie Bartolomeo, EVP, Creative Director; Drew Desjardins, EVP, Chief Strategy Officer; Annemarie Armstrong, EVP, Director of Client Services; John Kemble, EVP, Creative Producer. (Photo: Business Wire)
Fishawack’s goal is to increase the range of healthcare communications services that it can offer to commercial and medical affairs teams. It now has healthcare creative agencies that span East to West Coast USA and Europe.
“Dudnyk brings to Fishawack a particular expertise in rare diseases, oncology, and launching breakthrough molecular medicines,” explains Christopher Tobias, President of Dudnyk. “Our seasoned team will complement Fishawack’s already expansive offering, especially in the area of commercial strategy and creative expertise.”
“Fishawack has wanted to add an East Coast healthcare marketing agency of scale and is pleased to have found that partnership with Dudnyk,” explains Oliver Dennis, CEO of Fishawack Group of Companies. “The leadership at Dudnyk clearly cares about their people, their clients, and the rare disease and oncology patients they serve. The organization’s values are very much aligned with ours.”
Fishawack is a significant provider of healthcare communication services to both medical affairs and marketing teams. Its history of acquisitions is based on the belief that the teams are stronger together than individually. “It’s not just about acquiring,” said Gail Flockhart, Group President, “it’s about making the synergies real, which means connecting talent across the organization. The best part of every acquisition is discovering what we can learn from each other.”
“Fishawack is unlike traditional networks that make introductions as client needs arise; instead, we form high-performing, inter-company business relationships early on,” says Oliver Dennis. “This is important to our clients who depend on continuity of relationships and teams they can depend on. We’re currently undergoing a rebranding of Fishawack that reflects these core beliefs, and we’re looking forward to sharing this with the healthcare marketing community in the near future.”
Fishawack received corporate finance and legal support from Rick Stark and Phil Hall of KPMG and George Danczak and James Finney of Addleshaw Goddard LLP (UK), respectively. Their financial sponsor is LDC.
For more information about the Fishawack Group, please contact Gail Flockhart, Group President, at gail.flockhart@fishawack.com . For more information about Dudnyk, please contact Christopher Tobias, PhD, President, at ctobias@dudnyk.com .
About the Fishawack Group
The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in the UK (Knutsford, Oxford, London, and Brighton), the USA (Philadelphia, PA, and San Diego, CA), Switzerland (Basel), and India (Hyderabad).
Fishawack comprises two international divisions, Fishawack Medical Communications, developing and delivering services in the fields of medical communications, scientific engagement, publications, market access, strategic consultancy, and thought leader consultancy, and Fishawack Creative, offering strategic planning, creative development, advertising and promotion, and tactical execution.
We have built our reputation on excellence, creativity, and transparency.
About Dudnyk
Independently owned for the past 25 years, Dudnyk is an award-winning, full-service healthcare advertising agency that specializes in creating insight-driven, authentic brand experiences that unite specialty physicians and their patients. They leverage strategic, scientific, and highly creative capabilities to serve clients in the biotech, pharmaceutical, and medical device industries. Dudnyk offers a unique culture, fosters individual career growth, and promotes collaboration among all disciplines. Learn more at dudnyk.com or @DudnykHealth.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190320005204/en/
Contact information
Fishawack Group
Gail Flockhart, Group President
gail.flockhart@fishawack.com
or
Dudnyk
Christopher
Tobias, PhD, President
ctobias@dudnyk.com
About Business Wire
Business Wire(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Antognolla at International Hospitality Investment Forum: Growing Interest in the Italian Market from Hotel Operators and Investors25.4.2024 16:39:00 CEST | Press release
Antognolla Resort & Residences joined world-class hospitality experts at the Hospitality Investment Forum EMEA (IHIF EMEA) on 15-17 April in Berlin. With over 2,500 attendees this year, IHIF EMEA remains one of the largest gatherings of industry professionals in the region. Hospitality experts and event participants reaffirmed the growing interest among hotel operators in Italy, evident from the number of prestigious international brands entering the Italian market. The hospitality market in the country is becoming more identity-driven, with the majority of hotel keys in the upscale and luxury category being branded. International operators are increasingly attracted to the country year by year: almost 70% of the properties in the pipeline will belong to international chains by 2026. Andrey Yakunin, Chairman of the Board of Directors of Antognolla Resort & Residences commented: “As international experts discussed during IHIF, identity-driven, branded projects are set to become the lead
Digital Transformation’s Next Era: Generative AI and Laserfiche 12 at 2024 Empower Conference25.4.2024 16:30:00 CEST | Press release
Preparing organizations for the next AI-driven phase of digital transformation is on the agenda at the 2024 Empower conference, hosted by Laserfiche — the leading SaaS provider of intelligent content management and business process automation — in Las Vegas through April 25. Laserfiche shines a spotlight on solutions that reduce complexity and accelerate information flow across the enterprise to help organizations manage increasing amounts of data. Empower attendees got an early look at the latest Laserfiche AI features, including Laserfiche AI Document Summarization. The new offering, powered by generative AI, eliminates tedious sifting through documents by generating concise summaries of documents containing either text or transcribed audio. Laserfiche AI Document Summarization, which represents one milestone in the Laserfiche AI vision to transform the workplace, will be available in the upcoming Laserfiche Cloud release on April 30, 2024. “At Laserfiche, we believe AI will impact p
Alpha Blue Ocean Group and Europlasma, Expert in Depollution Solutions, Announce the Signing of a New €30 Million Financing Agreement25.4.2024 16:00:00 CEST | Press release
Environmental Performance Financing (EPF), a subsidiary of the Alpha Blue Ocean group, is proud to announce its collaboration with Europlasma (ALEUP:FP), a leader in depollution, material recovery, and decarbonation solutions, for the establishment of a bond financing arrangement. This financing aims to support the Group's growth and development, particularly in key initiatives such as: The acquisition of MG-Valdunes: Europlasma has obtained the green light for the acquisition of MG-Valdunes' business assets, a crucial step towards strengthening industrial sovereignty and relaunching Valdunes' historic activities. The development of the Forges de Tarbes: Funds will also be allocated to increasing the production capacities of the Forges de Tarbes, which are facing growing demand, particularly in the defense sector. The continued development of historical activities: A significant portion of the funds will be dedicated to the ongoing development of depollution, decarbonation, and hazardo
Interactive Brokers Announces Extended Trading Hours for US Treasury Bonds25.4.2024 16:00:00 CEST | Press release
Interactive Brokers (Nasdaq: IBKR), an automated global electronic broker, today announced a significant expansion of trading hours for US Treasury bonds on its platform. Clients around the world can now trade US Treasury bonds for 22 hours each day. The trading session closes daily at 5:00 pm Eastern Time (ET), reopens at 8:00 pm Eastern Daylight Time (EDT) and continues until 5:00 pm the following day. During Eastern Standard Time (EST), the market operates from 7:00 pm to 5:00 pm. This is a significant extension from the previous nine hours per day. This groundbreaking expansion caters especially to Interactive Brokers' global clients, allowing them to trade US Treasuries during their local trading hours. In addition, all clients are now able to respond swiftly to global market news and economic events as they occur, regardless of time or location. "The extension of trading hours for US Treasury bonds represents a significant enhancement to our offerings," said Thomas Frank, Executi
Cannatrol, Creators of Breakthrough Postharvest Cannabis Technology, Receive Two European Patent Approvals25.4.2024 14:03:00 CEST | Press release
Cannatrol, the creators of the only total dry, cure and store system for the cannabis industry, announced today the approval of two European patents for its Vaportrol® Technology, protecting the proprietary technology throughout the European Union. “As the European cannabis industry grows, demand for precision drying, curing and storage technologies continues to expand,” said David Sandelman, co-founder, COO and CTO of Cannatrol. “Cannatrol’s proven environmental-control system ensures top-quality cannabis through a repeatable, consistent process, and it’s appropriate for any scale of cultivation, from large-scale greenhouse production to home growers.” Cannatrol’s patented postharvest technology is proven to increase yields and curing efficiency, and delivers on average 16% higher terpene retention when compared to traditional drying and curing methods, according to independent testing by The Cannabis Research Coalition. Throughout drying, curing and storage, the environment will stay